| Overview |
| bsm-90122r-50µL |
| Matrix metallopeptidase 14 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human MMP14 |
| 151-182/582 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 4323 |
| P50281 |
| MMP14; Matrix Metallopeptidase 14; MT1-MMP; Matrix Metallopeptidase 14 (Membrane-Inserted); Membrane-Type-1 Matrix Metalloproteinase; Membrane Type 1 Metalloprotease; Matrix Metalloproteinase-14; EC 3.4.24.80; MT-MMP 1; MMP-14; MMP-X1; MT1MMP; MTMMP1; Matrix Metalloproteinase 14 (Membrane-Inserted); Membrane Type 1-Matrix Metalloproteinase; Membrane-Type Matrix Metalloproteinase 1; EC 3.4.24; MT-MMP; WNCHRS |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |